相关实验视频

Updated: Jun 5, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

一种基于VNAR抗体的新型鱼免疫毒素,针对TROP-2进行癌症治疗

Xiaozhi Xi^1,2,3, Yanqing Wang², Guiqi An²

¹College of Marine Science and Biological Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.

Acta pharmaceutica Sinica. B

|December 12, 2024

概括

一种针对TROP-2的新型重组免疫毒素显示出对癌症治疗的希望. 这种来自鱼抗体的免疫毒素5G8-PE38在体外和体内表现出显著的抗瘤活性.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
生物技术是生物技术.

背景情况:

TROP-2是一种与瘤相关的抗原,驱动着上皮细胞瘤的进展.
针对TROP-2的抗体与药物联合体 (ADC) 显示出有效性,但在固体瘤中面临挑战.
ADCs的局限性包括高分子量,瘤透率低,细胞毒性有效载荷释放.

研究的目的:

开发一种针对TROP-2的新型抗癌疗法.
为了克服ADCs的局限性,使用更小,更透的模式.
为了评估针对TROP-2的复合免疫毒素的疗效.

主要方法:

免疫球蛋白新抗原受体 (VNAR) 菌体显示库的鱼可变域的创建.
特定于TROP-2的VNAR克隆5G8的鉴定和特征.
将VNAR-5G8与一个截断的Pseudomonas外毒素 (PE38) 融合在一起,产生免疫毒素5G8-PE38.
在体外和体内对5G8-PE38抗瘤活性的评估.

主要成果:

VNAR-5G8对TROP-2表达细胞具有很高的亲和力和细胞内化.
VNAR-5G8在TROP-2上识别了一个隐藏的表位 (CRD和TY-1).
重组免疫毒素5G8-PE38对固体瘤表现出显著的抗瘤活性.

结论:

鱼VNAR抗体在癌症治疗中在尺寸和组织透方面具有优势.
针对TROP-2的免疫毒素5G8-PE38是新型癌症治疗的有希望的候选人.
这种方法可以克服与固体瘤治疗中的传统ADCs相关的局限性.

关键词:

这是一种抗瘤药物.乳腺癌是什么? 乳腺癌是什么皮质体的识别皮质体的识别免疫毒素是一种免疫毒素.一个纳米人体.伪omonas外毒素A是一种外毒毒素.鱼VNAR (维纳尔语) 的意思在TROP-2中.

更多相关视频

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...